| Announce Date | 10/23/2025 |
| EPS Normalized Actual | $8.25 (Beat by $1.96) |
| EPS GAAP Actual | $8.25 (Beat by $1.96) |
| Revenue Actual | $2.45097B |
| Revenue Surprise | Beat by $2450.97M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.37 |
| EPS GAAP Estimate | $3.37 |
| Revenue Estimate | $2.36224713B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 3 |
| Dec 2027 | 22.01825 | 58.3 | 21.39674 | 22.34596 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 8.26 | 5.16697 | 2.45097B | 26.05% | 682.24M |
| FQ2 2025 (Jun 2025) | 6.54 | 3.45036 | 2.17332B | 16.7% | 429.58M |
| FQ1 2025 (Mar 2025) | 4.77 | 2.50364 | 1.83129B | 16.07% | 222.03M |
| FQ4 2024 (Dec 2024) | 4.1 | 1.1007 | 1.8678B | 27.32% | 159.8M |
| FQ3 2024 (Sep 2024) | 4.1 | 4.1 | 1.81237B | 23.96% | 1812.37M |
| FQ2 2024 (Jun 2024) | 3.75 | 3.75 | 1.81029B | 28.39% | 1810.29M |
| FQ1 2024 (Mar 2024) | 2.7 | 2.7 | 1.53702B | 23.58% | 1537.02M |
| FQ4 2023 (Dec 2023) | 2.56 | 2.56 | 1.35757B | 17.71% | 1357.57M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
3.37
Consensus Revenue Estimates
2.36224713B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 7.39 | -- | 7.05169 | 7.83248 | 1 |
| FQ3 2027 (Sep 2027) | 8.7 | -- | 8.30172 | 9.22092 | 1 |
| FQ2 2027 (Jun 2027) | 8.06 | -- | 7.69102 | 8.5426 | 1 |
| FQ1 2027 (Mar 2027) | 5.75 | -- | 5.48677 | 6.09429 | 1 |
| FQ4 2026 (Dec 2026) | 4.73 | -- | 4.62497 | 4.801 | 1 |
| FQ3 2026 (Sep 2026) | 5.14 | -60.7 | 5.02587 | 5.21715 | 1 |
| FQ2 2026 (Jun 2026) | 4.68 | -39.74 | 4.57608 | 4.75025 | 1 |
| FQ1 2026 (Mar 2026) | 3.37 | -41.54 | 3.29517 | 3.42058 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.55B | -- | 2.46B | 2.67B | 2 |
| FQ3 2027 (Sep 2027) | 2.75B | -- | 2.66B | 2.88B | 2 |
| FQ2 2027 (Jun 2027) | 2.68B | -- | 2.59B | 2.81B | 2 |
| FQ1 2027 (Mar 2027) | 2.26B | -- | 2.18B | 2.36B | 2 |
| FQ4 2026 (Dec 2026) | 2.7B | -- | 2.65B | 2.73B | 1 |
| FQ3 2026 (Sep 2026) | 2.58B | 5.02 | 2.54B | 2.61B | 1 |
| FQ2 2026 (Jun 2026) | 2.47B | 11.97 | 2.43B | 2.5B | 1 |
| FQ1 2026 (Mar 2026) | 2.36B | 22.48 | 2.32B | 2.39B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.09303 | 8.26 | 5.16697 | 62.55% |
| FQ2 2025 (Jun 2025) | 3.08964 | 6.54 | 3.45036 | 52.76% |
| FQ1 2025 (Mar 2025) | 2.26636 | 4.77 | 2.50364 | 52.49% |
| FQ4 2024 (Dec 2024) | 2.9993 | 4.1 | 1.1007 | 26.85% |
| FQ3 2024 (Sep 2024) | 4.1 | 4.1 | 100% | |
| FQ2 2024 (Jun 2024) | 3.75 | 3.75 | 100% | |
| FQ1 2024 (Mar 2024) | 2.7 | 2.7 | 100% | |
| FQ4 2023 (Dec 2023) | 2.56 | 2.56 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.77B | $2.45B | $682.24M | 27.84% |
| FQ2 2025 (Jun 2025) | $1.74B | $2.17B | $429.58M | 19.77% |
| FQ1 2025 (Mar 2025) | $1.61B | $1.83B | $222.03M | 12.12% |
| FQ4 2024 (Dec 2024) | $1.71B | $1.87B | $159.8M | 8.56% |
| FQ3 2024 (Sep 2024) | $0B | $1.81B | $1812.37M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.81B | $1810.29M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.54B | $1537.02M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.36B | $1357.57M | 100% |